Time-dependent differences of repeated administration with Δ9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by μ-opioid and CB1-cannabinoid receptors in the caudate-putamen

被引:55
作者
Corchero, J
Romero, J
Berrendero, F
Fernandez-Ruiz, J
Ramos, JA
Fuentes, JA
Manzanares, J
机构
[1] Univ Complutense Madrid, Fac Farm, Dept Farmacol, Madrid 28040, Spain
[2] Univ Complutense Madrid, Unidad Cartog Cerebral, Inst Pluridisciplinar, Madrid 28040, Spain
[3] Univ Complutense Madrid, Fac Med, Dept Bioquim & Biol Mol, Madrid 28040, Spain
来源
MOLECULAR BRAIN RESEARCH | 1999年 / 67卷 / 01期
关键词
Delta(9)-tetrahydrocannabinol; proenkephalin; cannabinoid receptor; mRNA; S-35]GTP gamma binding; caudate-putamen;
D O I
10.1016/S0169-328X(99)00053-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The purpose of the present study was to examine the time-related effects of repeated administration of Delta 9-tetrahydrocannabinol during 1, 3, 7 and 14 days on cannabinoid and mu-opioid receptor agonist-stimulated [S-35]GTP gamma S binding, and CB1 cannabinoid receptor and proenkephalin gene expression in the caudate-putamen, Repeated administration with Delta 9-tetrahydrocannabinol produced a time-related reduction in cannabinoid receptor synthesis and activation of signal transduction mechanisms in the caudate-putamen. Indeed, WIN-55.212-2-stimulated [S-35]GTP gamma S binding decreased 24% on day 1 and then progressively decreased finding a 42% decrease on day 14. Similarly, CB1 cannabinoid receptor mRNA levels decreased (22%) on day 3, reaching 50% reduction on day 7. In contrast, a pronounced increase is detected in DAMGO-stimulated [S-35]GTP gamma S binding and proenkephalin mRNA levels in the caudate-putamen. The highest degree of increase was reached on day 7 of the treatment (35% of proenkephalin mRNA levels and 62% of DAMGO-stimulated [S-35]GTP gamma S binding) and then values slightly decreased on day 14. Taken together, the results of the present study indicate that, in the caudate-putamen, repeated administration with Delta 9-tetrahydrocannabinol produces a time-related increase in proenkephalin gene expression and mu-opioid receptor activation of G-proteins, and a time-related decrease in CB1 cannabinoid receptor gene expression and reduction in CB1 cannabinoid receptor activation of G-proteins. These results also suggest a possible interaction between the cannabinoid and opioid systems in the caudate-putamen which may be potentially relevant in the understanding of the alterations of motor behavior that occur after prolonged exposure to cannabinoids. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:148 / 157
页数:10
相关论文
共 40 条
[1]   DEVELOPMENT OF BEHAVIORAL TOLERANCE TO DELTA-9-THC WITHOUT ALTERATION OF CANNABINOID RECEPTOR-BINDING OR MESSENGER-RNA LEVELS IN WHOLE-BRAIN [J].
ABOOD, ME ;
SAUSS, C ;
FAN, F ;
TILTON, CL ;
MARTIN, BR .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 46 (03) :575-579
[2]   MOLECULAR ASPECTS OF NEUROPEPTIDE REGULATION AND FUNCTION IN THE CORPUS STRIATUM AND NUCLEUS-ACCUMBENS [J].
ANGULO, JA ;
MCEWEN, BS .
BRAIN RESEARCH REVIEWS, 1994, 19 (01) :1-28
[3]  
[Anonymous], PHARM ANAL DRUG RECE
[4]  
Breivogel CS, 1997, J NEUROCHEM, V68, P1462
[5]   Delta-9-tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the rat [J].
Corchero, J ;
Avila, MA ;
Fuentes, JA ;
Manzanares, J .
LIFE SCIENCES, 1997, 61 (04) :PL39-PL43
[6]   Delta(9)-tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus [J].
Corchero, J ;
Fuentes, JA ;
Manzanares, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 323 (2-3) :193-195
[7]   DOWN-REGULATION OF RAT-BRAIN CANNABINOID BINDING-SITES AFTER CHRONIC DELTA-9-TETRAHYDROCANNABINOL TREATMENT [J].
DEFONSECA, FR ;
GORRITI, MA ;
FERNANDEZRUIZ, JJ ;
PALOMO, T ;
RAMOS, JA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 47 (01) :33-40
[8]   ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949
[9]  
DEWEY WL, 1986, PHARMACOL REV, V38, P151
[10]   MOLECULAR-CLONING OF A HUMAN CANNABINOID RECEPTOR WHICH IS ALSO EXPRESSED IN TESTIS [J].
GERARD, CM ;
MOLLEREAU, C ;
VASSART, G ;
PARMENTIER, M .
BIOCHEMICAL JOURNAL, 1991, 279 :129-134